The American Biotech Landscape: Investment, Innovation, and Hubs
Update: 2025-09-06
Description
We map the transition of science into companies in the USA. Hear how funding cycles, NIH/SBIR grants, talent pipelines, universities, CDMOs, and clinical-trial access shape each hub. Educational only; not investment advice.
Comments
In Channel




















